Health Improvement Scotland and NHS Scotland Logos

Scottish Palliative Care Guidelines print pdf

References

1. Twycross R, Wilcock A. Palliative Care Formulary PCF4+  (4th edition) 2011, Palliativedrugs.com Ltd., Nottingham accessed at http://nhs.palliativedrugs.com/naloxone.html on 07 May 2013

2. National Patient Safety Agency. Safer practice notice 2006/12

3. Adult Emergencies Handbook. NHS Lothian: University Hospitals Division.?

4. Electronic Medicines Compendium. www.medicines.org.uk/naloxone accessed at http://www.medicines.org.uk/emc/medicine/21095/SPC/Naloxone+400+micrograms+ml+solution+for+Injection+(hameln)/ on 07 May 2013

5. Miaskowski C et al. (2008) Principles of analgesic use in the treatment of acute pain and cancer pain (6e). American Pain Society, Skokie, Illinois, p. 31

6. The American Heart Association. Guidelines 2005 for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation. 2005; 112(Suppl I)

7. Mercadante.(2003)  Naloxone in treating central adverse effects during opioid titration for cancer pain. Journal of pain and symptom management:vol:26 iss:2 691 -693

8. Manfredi P, Ribeiro S, Chandler S, et al. Inappropriate use of naloxone in cancer patients with pain. J Pain Symptom Manage 1996;11:131–134